The CONSORT Statement: Revised recommendations for improving the quality of reports of parallel group randomized trials 2001 - German version;Das CONSORT Statement: Überarbeitete Empfehlungen zur Qualitätsverbesserung von Reports randomisierter Studien im Parallel-Design

Deutsche Medizinische Wochenschrift

Volumn 129, Issue , 2004, Pages T16-T20

  Moher, D ^a   Schulz, K F ^a   Altman, D G ^a  

^a Deutsches Cochrane Zentrum   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 25144514904     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-2004-836117     Document Type: Article

References (30)

1. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273: 408-412
2. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, Tugwell P. Does the quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998; 352: 609-613
3. Jadad AR, Boyle M, Cunningham C, Kim M, Schachar R. Treatment of Attention-Deficit/Hyperactivity Disorder. Evidence Report/Technology Assessment No.11 Prepared by McMaster University under Contract No. 290-97-0017, 2000
4. Thornley B, Adams CE. Content and quality of 2000 controlled trials in schizophrenia over 50 years. BMJ 1998; 317: 1181-1184
5. Hotopf M, Lewis G, Normand C. Putting trials on trial-the costs and consequences of small trials in depression: a systematic review of methodology. J Epidemiol Community Health 1997; 51: 354-358
6. Dickinson K, Bunn F, Wentz R, Edwards P, Roberts I. Size and quality of randomised controlled trials in head injury: review of published studies. BMJ 2000; 320: 1308-1311
7. Begg CB, Cho MK, Eastwood S, Horton R, Moher D, Olkin I, Rennie D, Schulz KF, Simel DL, Stroup DF. Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA 1996; 276: 637-639
8. Freemantle N, Mason JM, Haines A, Eccles MP. CONSORT: an important step toward evidence-based health care. Ann Intern Med 1997; 126: 81-83
9. Altman DG. Better reporting of randomized controlled trials: the CONSORT statement. BMJ 1996; 313: 570-571
10. Schulz KF. The quest for unbiased research: randomized clinical trials and the CONSORT reporting guidelines. Ann Neurol 1997; 41: 569-573
11. Huston P, Hoey J. CMAJ endorses the CONSORT statement. CMAJ 1996; 155: 1277-1279
12. Davidoff F. News from the International Committee of Medical Journal Editors. Ann Intern Med 2000; 133: 229-231
13. http://www.consort-statement.org (accessed, Feb. 15, 2001).
14. Moher D, Jones A, Lepage L for the CONSORT Group. Use of the CONSORT statement and quality of reports of randomized trials: a comparative before and after evaluation? JAMA 2001; 285: 1992-1995
15. Egger M, Jüni P, Bartlett C for the CONSORT Group. The value of patient flow charts in reports of randomized controlled trials: bibliographic study. JAMA 2001; 285: 1996-1999
16. Meinert CL. Beyond CONSORT: Need for improved reporting standards for clinical trials. JAMA 1998; 279: 1487-1489
17. Chalmers I. Current Controlled Trials: an opportunity to help improve the quality of clinical research. Curr Control Trials Cardiovasc Med 2000; 1: 3-8
18. III. Bailer JC, Mosteller F. Guidelines for statistical reporting in articles for medical journals: amplifications and explanations. Ann Intern Med 1988; 108: 266-273
19. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gøtzsche PC, Lang T for the CONSORT group. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Annals of Internal Medicine 2001; 134: 663-694
20. Elbourne DR, Campbell MK. Extending the CONSORT statement to cluster randomised trials: for discussion. Stats Med 2001; 20: 489-496
21. Hollis S, Campbell F. What is meant by intention-to-treat analysis? Survey of published randomized controlled trials. BMJ 1999; 319: 670-674
22. Ruiz-Canela M, Martinez-Gonzalez MA, de Irala-Estevez J. Intention-to-treat analysis is related to methodological quality. BMJ 2000; 320: 1007
23. Lee YJ, Ellenberg JH, Hirtz DG, Nelson KB. Analysis of clinical trials by treatment actually received: is it really an option? Stat Med 1991; 10: 1595-1605
24. Bentzen SM. Towards evidence based radiation oncology: improving the design, analysis, and reporting of clinical outcome studies in radiotherapy. Radiother Oncol 1998; 46: 5-18
25. O'Toole LB. MRC uses checklist similar to CONSORTs. BMJ 1997; 314: 1127
26. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF for the QUOROM group. Improving the quality of reports of meta-analyses of randomized controlled trials: the QUOROM statement. Lancet 1999; 354: 1896-1900
27. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 2000; 283: 2008-2012
28. Siegel JE, Weinstein MC, Russell LB, Gold MR. Recommendations for reporting cost-effectiveness analysis. JAMA 1996; 276: 1339-1341
29. Neumann PJ, Stone PW, Chapman RH, Sandberg EA, Bell CM. The Quality of Reporting in Published Cost-Utility Analyses, 1976-1997. Ann Intern Med 2000; 132: 964-972
30. Altman DG. The scandal of poor medical research. BMJ 1994; 308: 283-284